跳至主要内容
临床试验/EUCTR2015-004251-47-BE
EUCTR2015-004251-47-BE进行中(未招募)1 期

Validation of central venous (Port A Cath®) blood draws for ciprofloxacin pharmacokinetic research in patients under treatment for childhood cancer. - Cipro-onco-validation

Z Brussel0 个研究点目标入组 15 人开始时间: 2015年10月12日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Children who
  • are between 1 month and 18 years of age
  • are under treatment for any type of childhood cancer
  • use ciprofloxacin intravenous for selective bowel decontamination as part of regular treatment
  • have a PAC (port a cath) for intravenous medication and blood draws.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 15
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Children will be excluded from this study if we are unable to
  • obtain informed consent of both parents and assent of the child (if he/she is over 12 years of age)
  • aspire blood from the PAC (port a cath).

研究者

发起方
Z Brussel

相似试验